features: Disease Biology

VJHemOnc is excited to present the latest developments in the role of chemotherapy across lymphomas

VJHemOnc is pleased to bring you a feature exploring the emerging applications of MRD in multiple myeloma.

VJHemOnc is pleased to bring you a feature exploring the latest thinking on the application of MRD in AML trials…

VJHemOnc is pleased to bring you a feature exploring the latest developments in the treatment of NHL, with leading experts…

VJHemOnc is excited to bring you the latest updates from the 2022 third annual Texas MPN Workshop, which brought together…

Learn about the importance of performing genomic testing in CLL and how this impacts diagnosis, prognosis and treatment decisions.

VJHemOnc is excited to bring you the latest updates from The Texas MPN Workshop: Second Annual Workshop and Meeting, which brought…

VJHemOnc was official Media Partner for the ERIC 2020 Virtual Meeting, New Frontiers in CLL Research, which took place on 1-3…

VJHemOnc are excited to present late-breaking abstracts and key trial updates announced at this year’s virtual EHA meeting!

Published in Blood, a special report has proposed a new, distinct subtype of myelodysplastic syndromes (MDS) based on the presence…

Chimeric antigen receptor T-cell (CAR-T) therapies have proven particularly successful in hematological malignancies. However, CAR T-cells still underperform when used…

VJHemOnc is pleased to bring e-learning webcasts from iwNHL 2018- explore updates in lymphoma!